BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Shrivastav D, Singh DD, Mir R, Mehra P, Mehta V, Dabla PK. Comparative analysis of Nε-carboxymethyl-lysine and inflammatory markers in diabetic and non-diabetic coronary artery disease patients. World J Diabetes 2023; 14(12): 1754-1765 [PMID: 38222780 DOI: 10.4239/wjd.v14.i12.1754]
URL: https://www.wjgnet.com/1948-9358/full/v14/i12/1754.htm
Number Citing Articles
1
Rositsa Tsekovska, Evan Gatev, Roumyana Mironova, Simona Kerezieva, Siyana Ilieva, Teodora Ilieva, Bilyana Vasileva, Toshimitsu Niwa, Daniela Popova, Vasil Vasilev. Serum Levels of Nε-(Carboxymethyl)-Lysine in Chronic Kidney Disease and Type 2 Diabetes MellitusBiomedicines 2025; 13(7): 1672 doi: 10.3390/biomedicines13071672
2
Zhuo-Han Li, Xin-Yao Wang, Qi Luo. The roles of advanced glycation end products in cardiovascular diseases: from mechanisms to therapeutic strategiesFrontiers in Cardiovascular Medicine 2025; 12 doi: 10.3389/fcvm.2025.1637252
3
Sonia Eiras. Nε-carboxymethyl-lysine and inflammatory cytokines, markers and mediators of coronary artery disease progression in diabetesWorld Journal of Diabetes 2024; 15(4): 575-578 doi: 10.4239/wjd.v15.i4.575